Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01083771 · ClinicalTrials.gov registry record · NA

Med Diet Prevention Metabolic Syndrome Men Undergoing Androgen Deprivation Therapy Prostate Cancer

A NA study of Prostate Cancer, sponsored by Brown University.

Completed
Registry status
NA
Development phase
21
Enrollment target
1
Study location

NCT01083771 is a NA study of Prostate Cancer that has completed, run by Brown University. The registered enrollment target is 21 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01083771, a NA study of Prostate Cancer, has completed, sponsored by Brown University.

COMPLETED
Registry status
NA
Development phase
21 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess for changes in a patient's overall energy level and well-being (quality of life) after 8 weeks of dietary intervention.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Olive Oil

Study Locations (1)

Rhode Island

  • Miriam Hospital - Providence

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2009-02
Est. Completion 2012-08
Phase NA

Sponsor

Brown University

231 total trials

What the Registry Record Tells You About NCT01083771

The ClinicalTrials.gov registry entry for NCT01083771 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (97% lower). The listed sponsor is Brown University, which has 231 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Olive Oil is the first listed.

NCT01083771 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.

Frequently Asked Questions

What is clinical trial NCT01083771 about?

NCT01083771 is a clinical study titled "Med Diet Prevention Metabolic Syndrome Men Undergoing Androgen Deprivation Therapy Prostate Cancer". The purpose of this study is to assess for changes in a patient's overall energy level and well-being (quality of life) after 8 weeks of dietary intervention.

What is the current status of trial NCT01083771?

This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2009-02. Estimated completion is 2012-08.

What conditions does trial NCT01083771 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT01083771?

The interventions under investigation include: Olive Oil (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01083771?

This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01083771 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.